[A new drug against hip dysplasia?].
Clinical studies using a new drug for the treatment of hip dysplasia were done in approximately twenty dogs. Caniplasine was administered rather than combined treatment with phenylbutazone and a corticosteroid. The preliminary results show that this agent has a therapeutic effect. The precise mechanism of action is still obscure.
Gloudemans
M G
MG
D000818:Animals; D002118:Calcium / Q000008:administration & dosage; D003300:Copper / Q000008:administration & dosage; D004285:Dogs; D004338:Drug Combinations / Q000627:therapeutic use; D006618:Hip Dislocation, Congenital / Q000662:veterinary*; D006619:Hip Dysplasia, Canine / Q000188:drug therapy*; D008274:Magnesium / Q000008:administration & dosage; D010936:Plant Extracts / Q000008:administration & dosage* / Q000627:therapeutic use*; D012825:Silicon / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D010936:Plant Extracts; C054976:Caniplasine; D003300:Copper; D008274:Magnesium; D002118:Calcium; D012825:Silicon
Een nieuw geneesmiddel tegen heupdysplasie?